Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease

Autoimmunity

Volumn 48, Issue 3, 2015, Pages 181-188

  Burns, Jane C ^a   Touma, Ranim ^a   Song, Yali ^a   Padilla, Robert L ^a   Tremoulet, Adriana H ^a   Sidney, John ^b   Sette, Alessandro ^b   Franco, Alessandra ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Immune regulation; Immunotherapy; IVIG; Kawasaki disease; Natural Treg

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN; IL10 PROTEIN, HUMAN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOLOGIC FACTOR; INTERLEUKIN 10; PEPTIDE;

ADOLESCENT; ANTIGEN SPECIFICITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ACUTE DISEASE; ADULT; AMINO ACID SEQUENCE; CASE CONTROL STUDY; CHEMISTRY; CONVALESCENCE; CORONARY ARTERY DISEASE; DRUG EFFECTS; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; PATHOLOGY; PRIMARY CELL CULTURE; SECRETION (PROCESS); TIME;

ACUTE DISEASE; ADOLESCENT; ADULT; AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; CHILD; CONVALESCENCE; CORONARY ARTERY DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MOLECULAR SEQUENCE DATA; MUCOCUTANEOUS LYMPH NODE SYNDROME; PEPTIDES; PRIMARY CELL CULTURE; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 84928607095     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2015.1027817     Document Type: Article

References (17)

1. Jordan, M. S., A. Boesteanu, A. J. Reed, et al. 2001. Thymic selection of CD4+CD25+regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
2. Miyara, M., Y. Yoshioka, A. Kito, et al. 2009. Functional delineation and differentiation dinamic of human CD4+T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
3. Franco, A., R. Touma, Y. Song, et al. 2014. Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity 47: 95-104.
4. Ogata, S., C. Shimizu, A. Franco, et al. 2013. Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. PLoS One 8: e81448.
5. Franco, A., C. Shimizu, A. H. Tremoulet, and J. C. Burns. 2010. Memory T cells and characterization of peripheral T cell clones in acute Kawasaki disease. Autoimmunity 43: 317-324.
6. Franco, A., G. Almanza, J. C. Burns, et al. 2010. Endoplasmic reticulum stress drives a regulatory phenotype in human T cell clones. Cell. Immunol. 266: 1-6.
7. Burns, J. C., Y. Song, M. Bujold, et al. 2013. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin. Clin. Exp. Immunol. 174: 337-344.
8. Wang, P., J. Sidney, Y. Kim, et al. 2010. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11: 568.
9. Tangri, S., B. R. Mothé, J. Eisenbraun, et al. 2005. Rationally engineered therapeutic proteins with reduced immunogenicity. J. Immunol. 174: 3187-3196.
10. Oseroff, C., J. Sidney, M. F. Kotturi, et al. 2010. Molecular determinants of T cell epitope recognition to the common Timothy grass allergen. J. Immunol. 185: 943-955.
11. Oseroff, C., J. Sidney, R. Vita, et al. 2012. T Cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extracts. J. Immunol. 189: 1800-1811.
12. Lindestam Arlehamn, C. S., A. Gerasimova, F. Mele, et al. 2013. Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6 +Th1 subset. PLoS Pathog. 9: e1003130.
13. Alexander, J., J. Sidney, S. Southwood, et al. 1994. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1: 751-761.
14. Paul, S., R. V. Kolla, J. Sidney, et al. 2013. Evaluating the immunogenicity of protein drugs by applying in vitro MHC binding data and the immune epitope database and analysis resource. Clin. Dev. Immunol. 2013: 467852.
15. Arens, R., P. Wang, J. Sidney, et al. 2008. Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J. Immunol. 180: 6472-6476.
16. Burns, J. C., and M. P. Glode. 2004. Kawasaki syndrome. Lancet 364: 533-544.
17. De Groot, A. S., L. Moise, J. A. McMurry, et al. 2008. Activation of natural regulatory T cells by IG Fc-derived peptide "Tregitopes". Blood 112: 3303-3311.